🇺🇸 FDA
Pipeline program

Gemcitabine/Cisplatin

EudraCT 2016-004017-27

Phase 2 small_molecule active

Quick answer

Gemcitabine/Cisplatin for Upper Tract Urothelial Carcinoma is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Upper Tract Urothelial Carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials